 | • レポートコード：GIR-2104Z10475 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、小児用ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。小児用ワクチンの種類別市場規模（肺炎球菌、水痘、配合、ポリオウイルス、肝炎、MMR、小児ホルモン、HIB、アレルギー・呼吸器ワクチン、その他小児用ワクチン）、用途別市場規模（年齢（0-3）、年齢（3-12）、12歳以上）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・小児用ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithCline、Merck、Sanofi、Bristol-Myers Squibb、Abbott Laboratories、Eli Lilly、Pfizer、F. Hoffmann-La Roche、Novo Nordisk ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：肺炎球菌、水痘、配合、ポリオウイルス、肝炎、MMR、小児ホルモン、HIB、アレルギー・呼吸器ワクチン、その他小児用ワクチン ・用途別分析2016年-2026年：年齢（0-3）、年齢（3-12）、12歳以上 ・小児用ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・小児用ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・小児用ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・小児用ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・小児用ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Paediatric Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Paediatric Vaccine size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Paediatric Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Paediatric Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
MMR
Pediatric Hormones
HIB
Allergy and Respiratory vaccines
Other Pediatric vaccines
Market segment by Application, can be divided into
Age (0-3)
Age (3-12)
Age Above 12
Market segment by players, this report covers
GlaxoSmithCline
Merck
Sanofi
Bristol-Myers Squibb
Abbott Laboratories
Eli Lilly
Pfizer
F. Hoffmann-La Roche
Novo Nordisk
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Paediatric Vaccine
1.2 Classification of Paediatric Vaccine by Type
1.2.1 Overview: Global Paediatric Vaccine Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Paediatric Vaccine Revenue Market Share by Type in 2020
1.2.3 Pneumococcal
1.2.4 Varicella
1.2.5 Combinations
1.2.6 Poliovirus
1.2.7 Hepatitis
1.2.8 MMR
1.2.9 Pediatric Hormones
1.2.10 HIB
1.2.11 Allergy and Respiratory vaccines
1.2.12 Other Pediatric vaccines
1.3 Global Paediatric Vaccine Market by Application
1.3.1 Overview: Global Paediatric Vaccine Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Age (0-3)
1.3.3 Age (3-12)
1.3.4 Age Above 12
1.4 Global Paediatric Vaccine Market Size & Forecast
1.5 Global Paediatric Vaccine Market Size and Forecast by Region
1.5.1 Global Paediatric Vaccine Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Paediatric Vaccine Market Size by Region, (2016-2021)
1.5.3 North America Paediatric Vaccine Market Size and Prospect (2016-2026)
1.5.4 Europe Paediatric Vaccine Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Paediatric Vaccine Market Size and Prospect (2016-2026)
1.5.6 South America Paediatric Vaccine Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Paediatric Vaccine Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Paediatric Vaccine Market Drivers
1.6.2 Paediatric Vaccine Market Restraints
1.6.3 Paediatric Vaccine Trends Analysis
2 Company Profiles
2.1 GlaxoSmithCline
2.1.1 GlaxoSmithCline Details
2.1.2 GlaxoSmithCline Major Business
2.1.3 GlaxoSmithCline Paediatric Vaccine Product and Solutions
2.1.4 GlaxoSmithCline Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GlaxoSmithCline Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Paediatric Vaccine Product and Solutions
2.2.4 Merck Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Paediatric Vaccine Product and Solutions
2.3.4 Sanofi Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Paediatric Vaccine Product and Solutions
2.4.4 Bristol-Myers Squibb Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.5 Abbott Laboratories
2.5.1 Abbott Laboratories Details
2.5.2 Abbott Laboratories Major Business
2.5.3 Abbott Laboratories Paediatric Vaccine Product and Solutions
2.5.4 Abbott Laboratories Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Abbott Laboratories Recent Developments and Future Plans
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Paediatric Vaccine Product and Solutions
2.6.4 Eli Lilly Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Eli Lilly Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Paediatric Vaccine Product and Solutions
2.7.4 Pfizer Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 F. Hoffmann-La Roche
2.8.1 F. Hoffmann-La Roche Details
2.8.2 F. Hoffmann-La Roche Major Business
2.8.3 F. Hoffmann-La Roche Paediatric Vaccine Product and Solutions
2.8.4 F. Hoffmann-La Roche Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.9 Novo Nordisk
2.9.1 Novo Nordisk Details
2.9.2 Novo Nordisk Major Business
2.9.3 Novo Nordisk Paediatric Vaccine Product and Solutions
2.9.4 Novo Nordisk Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Novo Nordisk Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Paediatric Vaccine Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Paediatric Vaccine Players Market Share
3.2.2 Top 10 Paediatric Vaccine Players Market Share
3.2.3 Market Competition Trend
3.3 Paediatric Vaccine Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Paediatric Vaccine Revenue and Market Share by Type (2016-2021)
4.2 Global Paediatric Vaccine Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Paediatric Vaccine Revenue Market Share by Application (2016-2021)
5.2 Paediatric Vaccine Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Paediatric Vaccine Revenue by Type (2016-2026)
6.2 North America Paediatric Vaccine Revenue by Application (2016-2026)
6.3 North America Paediatric Vaccine Market Size by Country
6.3.1 North America Paediatric Vaccine Revenue by Country (2016-2026)
6.3.2 United States Paediatric Vaccine Market Size and Forecast (2016-2026)
6.3.3 Canada Paediatric Vaccine Market Size and Forecast (2016-2026)
6.3.4 Mexico Paediatric Vaccine Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Paediatric Vaccine Revenue by Type (2016-2026)
7.2 Europe Paediatric Vaccine Revenue by Application (2016-2026)
7.3 Europe Paediatric Vaccine Market Size by Country
7.3.1 Europe Paediatric Vaccine Revenue by Country (2016-2026)
7.3.2 Germany Paediatric Vaccine Market Size and Forecast (2016-2026)
7.3.3 France Paediatric Vaccine Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Paediatric Vaccine Market Size and Forecast (2016-2026)
7.3.5 Russia Paediatric Vaccine Market Size and Forecast (2016-2026)
7.3.6 Italy Paediatric Vaccine Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Paediatric Vaccine Revenue by Type (2016-2026)
8.2 Asia-Pacific Paediatric Vaccine Revenue by Application (2016-2026)
8.3 Asia-Pacific Paediatric Vaccine Market Size by Region
8.3.1 Asia-Pacific Paediatric Vaccine Revenue by Region (2016-2026)
8.3.2 China Paediatric Vaccine Market Size and Forecast (2016-2026)
8.3.3 Japan Paediatric Vaccine Market Size and Forecast (2016-2026)
8.3.4 South Korea Paediatric Vaccine Market Size and Forecast (2016-2026)
8.3.5 India Paediatric Vaccine Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Paediatric Vaccine Market Size and Forecast (2016-2026)
8.3.7 Australia Paediatric Vaccine Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Paediatric Vaccine Revenue by Type (2016-2026)
9.2 South America Paediatric Vaccine Revenue by Application (2016-2026)
9.3 South America Paediatric Vaccine Market Size by Country
9.3.1 South America Paediatric Vaccine Revenue by Country (2016-2026)
9.3.2 Brazil Paediatric Vaccine Market Size and Forecast (2016-2026)
9.3.3 Argentina Paediatric Vaccine Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Paediatric Vaccine Revenue by Type (2016-2026)
10.2 Middle East & Africa Paediatric Vaccine Revenue by Application (2016-2026)
10.3 Middle East & Africa Paediatric Vaccine Market Size by Country
10.3.1 Middle East & Africa Paediatric Vaccine Revenue by Country (2016-2026)
10.3.2 Turkey Paediatric Vaccine Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Paediatric Vaccine Market Size and Forecast (2016-2026)
10.3.4 UAE Paediatric Vaccine Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Paediatric Vaccine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Paediatric Vaccine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Paediatric Vaccine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Paediatric Vaccine Revenue (USD Million) by Region (2016-2021)
Table 5. Global Paediatric Vaccine Revenue Market Share by Region (2021-2026)
Table 6. GlaxoSmithCline Corporate Information, Head Office, and Major Competitors
Table 7. GlaxoSmithCline Major Business
Table 8. GlaxoSmithCline Paediatric Vaccine Product and Solutions
Table 9. GlaxoSmithCline Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Paediatric Vaccine Product and Solutions
Table 13. Merck Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sanofi Corporate Information, Head Office, and Major Competitors
Table 15. Sanofi Major Business
Table 16. Sanofi Paediatric Vaccine Product and Solutions
Table 17. Sanofi Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 19. Bristol-Myers Squibb Major Business
Table 20. Bristol-Myers Squibb Paediatric Vaccine Product and Solutions
Table 21. Bristol-Myers Squibb Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 23. Abbott Laboratories Major Business
Table 24. Abbott Laboratories Paediatric Vaccine Product and Solutions
Table 25. Abbott Laboratories Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly Major Business
Table 28. Eli Lilly Paediatric Vaccine Product and Solutions
Table 29. Eli Lilly Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Pfizer Corporate Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Paediatric Vaccine Product and Solutions
Table 33. Pfizer Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 35. F. Hoffmann-La Roche Major Business
Table 36. F. Hoffmann-La Roche Paediatric Vaccine Product and Solutions
Table 37. F. Hoffmann-La Roche Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 39. Novo Nordisk Major Business
Table 40. Novo Nordisk Paediatric Vaccine Product and Solutions
Table 41. Novo Nordisk Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Paediatric Vaccine Revenue (USD Million) by Players (2019-2021)
Table 43. Global Paediatric Vaccine Revenue Share by Players (2019-2021)
Table 44. Breakdown of Paediatric Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Paediatric Vaccine Players Head Office, Products and Services Provided
Table 46. Paediatric Vaccine Mergers & Acquisitions in the Past Five Years
Table 47. Paediatric Vaccine New Entrants and Expansion Plans
Table 48. Global Paediatric Vaccine Revenue (USD Million) by Type (2016-2021)
Table 49. Global Paediatric Vaccine Revenue Share by Type (2016-2021)
Table 50. Global Paediatric Vaccine Revenue Forecast by Type (2021-2026)
Table 51. Global Paediatric Vaccine Revenue by Application (2016-2021)
Table 52. Global Paediatric Vaccine Revenue Forecast by Application (2021-2026)
Table 53. North America Paediatric Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Paediatric Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Paediatric Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Paediatric Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Paediatric Vaccine Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Paediatric Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Paediatric Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Paediatric Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Paediatric Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Paediatric Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Paediatric Vaccine Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Paediatric Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Paediatric Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Paediatric Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Paediatric Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Paediatric Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Paediatric Vaccine Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Paediatric Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Paediatric Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Paediatric Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Paediatric Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Paediatric Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Paediatric Vaccine Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Paediatric Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Paediatric Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Paediatric Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Paediatric Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Paediatric Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Paediatric Vaccine Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Paediatric Vaccine Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Paediatric Vaccine Picture
Figure 2. Global Paediatric Vaccine Revenue Market Share by Type in 2020
Figure 3. Pneumococcal
Figure 4. Varicella
Figure 5. Combinations
Figure 6. Poliovirus
Figure 7. Hepatitis
Figure 8. MMR
Figure 9. Pediatric Hormones
Figure 10. HIB
Figure 11. Allergy and Respiratory vaccines
Figure 12. Other Pediatric vaccines
Figure 13. Paediatric Vaccine Revenue Market Share by Application in 2020
Figure 14. Age (0-3) Picture
Figure 15. Age (3-12) Picture
Figure 16. Age Above 12 Picture
Figure 17. Global Paediatric Vaccine Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 18. Global Paediatric Vaccine Revenue and Forecast (2016-2026) & (USD Million)
Figure 19. Global Paediatric Vaccine Revenue Market Share by Region (2016-2026)
Figure 20. Global Paediatric Vaccine Revenue Market Share by Region in 2020
Figure 21. North America Paediatric Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Europe Paediatric Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Asia-Pacific Paediatric Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. South America Paediatric Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Paediatric Vaccine Market Drivers
Figure 26. Paediatric Vaccine Market Restraints
Figure 27. Paediatric Vaccine Market Trends
Figure 28. GlaxoSmithCline Recent Developments and Future Plans
Figure 29. Merck Recent Developments and Future Plans
Figure 30. Sanofi Recent Developments and Future Plans
Figure 31. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 32. Abbott Laboratories Recent Developments and Future Plans
Figure 33. Eli Lilly Recent Developments and Future Plans
Figure 34. Pfizer Recent Developments and Future Plans
Figure 35. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 36. Novo Nordisk Recent Developments and Future Plans
Figure 38. Global Paediatric Vaccine Revenue Share by Players in 2020
Figure 39. Paediatric Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Paediatric Vaccine Revenue Market Share in 2020
Figure 41. Global Top 10 Players Paediatric Vaccine Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Paediatric Vaccine Revenue Share by Type in 2020
Figure 44. Global Paediatric Vaccine Market Share Forecast by Type (2021-2026)
Figure 45. Global Paediatric Vaccine Revenue Share by Application in 2020
Figure 46. Global Paediatric Vaccine Market Share Forecast by Application (2021-2026)
Figure 47. North America Paediatric Vaccine Sales Market Share by Type (2016-2026)
Figure 48. North America Paediatric Vaccine Sales Market Share by Application (2016-2026)
Figure 49. North America Paediatric Vaccine Revenue Market Share by Country (2016-2026)
Figure 50. United States Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Paediatric Vaccine Sales Market Share by Type (2016-2026)
Figure 54. Europe Paediatric Vaccine Sales Market Share by Application (2016-2026)
Figure 55. Europe Paediatric Vaccine Revenue Market Share by Country (2016-2026)
Figure 56. Germany Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Paediatric Vaccine Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Paediatric Vaccine Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Paediatric Vaccine Revenue Market Share by Region (2016-2026)
Figure 64. China Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Paediatric Vaccine Sales Market Share by Type (2016-2026)
Figure 71. South America Paediatric Vaccine Sales Market Share by Application (2016-2026)
Figure 72. South America Paediatric Vaccine Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Paediatric Vaccine Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Paediatric Vaccine Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Paediatric Vaccine Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Paediatric Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の小児用ワクチン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Paediatric Vaccine Market The global Paediatric Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…- 世界の肺炎球菌多価ワクチン市場 2021：企業別、地域別、種類・用途別 The Pneumococcal Vaccine Polyvalent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界のTBワクチン治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global TB Vaccine Treatment Market The global TB Vaccine Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界のピーナッツアレルギー用ワクチン市場 2021：企業別、地域別、種類・用途別 The Peanut Allergy Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界のダニ媒介性脳炎不活化ワクチン市場 2021：企業別、地域別、種類・用途別 The Tick-borne Encephalitis Inactivated Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…